PubRank

G J Offerhaus

Author PubWeight™ 172.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001 6.30
2 Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993 6.13
3 Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987 4.55
4 Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994 3.69
5 K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993 3.56
6 The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 2001 3.02
7 An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994 2.67
8 Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993 2.39
9 Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998 2.38
10 K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996 2.29
11 Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998 2.23
12 Desmoid tumours in familial adenomatous polyposis. Gut 1994 2.08
13 Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001 1.98
14 Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 1993 1.91
15 Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 1997 1.88
16 Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993 1.85
17 Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 1991 1.81
18 Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994 1.79
19 Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med 1987 1.76
20 Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989 1.73
21 Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 1998 1.73
22 Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001 1.71
23 Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol 2000 1.69
24 Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst 1991 1.64
25 Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007 1.60
26 Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut 1999 1.59
27 Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994 1.59
28 K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993 1.57
29 The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol 1998 1.56
30 Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999 1.51
31 Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol 2001 1.50
32 Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer 1999 1.50
33 Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet 1999 1.46
34 A patient with seven primary tumors of the upper aerodigestive tract: the process of field cancerization versus distant monoclonal expansion. Dis Esophagus 1997 1.43
35 Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998 1.42
36 Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res 1991 1.39
37 [Barrett esophagus and Barrett carcinoma]. Ned Tijdschr Geneeskd 1997 1.39
38 Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 1999 1.39
39 Familial pancreatic cancer. Ann Oncol 1999 1.33
40 The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur J Cancer 1995 1.32
41 Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol 2001 1.30
42 NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 2001 1.28
43 Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995 1.26
44 The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum 1990 1.25
45 The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer 1990 1.24
46 Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991 1.20
47 Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components. Mod Pathol 2000 1.18
48 Tumor-suppressor genes in pancreatic cancer. J Hepatobiliary Pancreat Surg 1998 1.17
49 Adenocarcinoma arising within a tailgut cyst: clinicopathological description and follow up of an unusual case. J Clin Pathol 1999 1.17
50 Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. Eur J Surg Oncol 2001 1.16
51 Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008 1.15
52 Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 1990 1.14
53 Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 1999 1.13
54 Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996 1.13
55 K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium. Am J Surg Pathol 1998 1.12
56 Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000 1.12
57 The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 1995 1.11
58 Local resection or pancreaticoduodenectomy for villous adenoma of the ampulla of Vater diagnosed before operation. Br J Surg 1997 1.11
59 Pathology of incipient pancreatic cancer. Ann Oncol 1999 1.10
60 Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 1998 1.09
61 Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut 1994 1.09
62 Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000 1.08
63 Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut 1991 1.07
64 Endoscopic screening for malignancy in the gastric remnant: the clinical significance of dysplasia in gastric mucosa. J Clin Pathol 1984 1.07
65 Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients. Am J Epidemiol 1991 1.06
66 Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential. Gastroenterology 1997 1.05
67 Cancer risk in collagenous colitis. Inflamm Bowel Dis 1999 1.05
68 Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer 1995 1.04
69 Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 1993 1.04
70 Influence of oral 15(R)-15-methyl prostaglandin E2 on human gastric mucosa. A light microscopic, cell kinetic, and ultrastructural study. Gastroenterology 1986 1.04
71 Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J Pathol 2000 1.01
72 CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastroenterol 1998 0.99
73 Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J Pathol 1996 0.98
74 Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem 1995 0.98
75 Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996 0.97
76 Occurrence of non-gastric cancer in the digestive tract after remote partial gastrectomy: analysis of an Amsterdam cohort. Int J Cancer 1990 0.96
77 CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Adv Cancer Res 2000 0.96
78 APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 1997 0.95
79 Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J Clin Pathol 2001 0.95
80 Gangliocytic paraganglioma of the appendix. Histopathology 2000 0.95
81 Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995 0.95
82 p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol 1998 0.95
83 K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 1998 0.95
84 Carcinogenesis after remote peptic ulcer surgery: the long-term prognosis of partial gastrectomy. Scand J Gastroenterol Suppl 1995 0.95
85 Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. Clin Cancer Res 1999 0.94
86 Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol 2000 0.94
87 Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus. Anal Quant Cytol Histol 1997 0.94
88 The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Am J Pathol 1992 0.94
89 Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol 1998 0.93
90 Pyloric gland adenoma of the main pancreatic duct. Am J Surg Pathol 1999 0.91
91 Atypical melanocytic proliferation associated with squamous cell carcinoma in situ of the esophagus. Virchows Arch 2000 0.91
92 The operated stomach: a premalignant condition? A prospective endoscopic follow-up study. Scand J Gastroenterol 1984 0.90
93 Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 1995 0.90
94 Partial gastrectomy: a risk factor for carcinoma of the pancreas? Hum Pathol 1987 0.90
95 Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol 2001 0.89
96 Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol 1996 0.88
97 Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product. J Clin Pathol 1995 0.88
98 Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma. Ann Surg Oncol 1998 0.87
99 Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. Clin Cancer Res 2001 0.87
100 Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients. Am J Pathol 1997 0.87
101 Molecular evidence of field cancerization in a patient with 7 tumors of the aerodigestive tract. Hum Pathol 2000 0.87
102 Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. J Pathol 2001 0.87
103 Heterotopic gastric mucosa of the cervical esophagus: a case of high-grade dysplasia treated with argon plasma coagulation and a case of adenocarcinoma. Gastrointest Endosc 2001 0.86
104 Local excision and mucosal advancement for anorectal ulceration in patients infected with human immunodeficiency virus. Br J Surg 1995 0.86
105 Recent developments in hereditary nonpolyposis colorectal cancer. Scand J Gastroenterol Suppl 1996 0.85
106 Intrauterine fetal death due to Farber disease: case report. Pediatr Dev Pathol 2000 0.84
107 Jan Peutz, Harold Jeghers and a remarkable combination of polyposis and pigmentation of the skin and mucous membranes. Fam Cancer 2001 0.83
108 Occult radiopaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpolyposis colorectal cancer. Gastroenterology 1987 0.83
109 Difference in expression of CD44 splice variants between proximal and distal adenocarcinoma of the large bowel. Br J Surg 1995 0.83
110 Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. Am J Gastroenterol 2000 0.82
111 Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut 1997 0.82
112 K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach. Hepatogastroenterology 1999 0.82
113 Clinical applications of detecting dysfunctional p53 tumor suppressor protein. Histol Histopathol 1999 0.81
114 Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg 2001 0.81
115 Gastric carcinoma: clinical, pathogenic, and molecular aspects. QJM 1997 0.81
116 p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis. Histochem J 1997 0.80
117 Molecular alterations in early gastric carcinomas. No apparent correlation with Helicobacter pylori status. Am J Clin Pathol 1999 0.80
118 Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis. Dis Esophagus 2012 0.80
119 Barrett oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues. Scand J Gastroenterol Suppl 2001 0.80
120 Laparoscopic ultrasonography of abdominal lymph nodes: correlation with pathologic findings. J Ultrasound Med 1998 0.80
121 Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas. Pancreas 1998 0.79
122 Absence of ras gene mutations in early gastric carcinomas. Gut 1995 0.79
123 Long-term prognosis after partial gastrectomy for benign conditions. Survival and smoking-related death of 2633 Amsterdam postgastrectomy patients followed up since surgery between 1931 and 1960. Gastroenterology 1991 0.78
124 Micrometastases in bone marrow of patients with suspected pancreatic and ampullary cancer. Eur J Surg Oncol 2001 0.78
125 Molecular diagnosis of cancer and micrometastases. Adv Anat Pathol 1998 0.78
126 Diagnostic p53 immunostaining of endobiliary brush cytology: preoperative cytology compared with the surgical specimen. Cancer 1999 0.78
127 Expression of HLA-DQ antigens in the small-intestinal mucosa of patients with coeliac disease. Scand J Gastroenterol 1991 0.78
128 DNA quantitation of distal bile duct carcinoma measured by image and flow cytometry. Anal Quant Cytol Histol 1999 0.77
129 Comprehensive Cancer Centre Amsterdam Barrett Advisory Committee: first results. Neth J Med 2001 0.77
130 Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. Br J Cancer 1997 0.77
131 p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999 0.77
132 Peutz-Jeghers polyps, dysplasia, and K-ras codon 12 mutations. Gut 1997 0.77
133 Cell proliferation kinetics in the gastric remnant. Eur J Cancer Clin Oncol 1985 0.77
134 Remote partial gastrectomy as a risk factor for pancreatic cancer: potential for preventive strategies. Ann Oncol 1999 0.77
135 Short-term results of gastrectomy with Roux-en-Y or Billroth II anastomosis for peptic ulcer. A prospective comparative study. Hepatogastroenterology 1992 0.76
136 p53 expression as a prognostic determinant in resected distal bile duct carcinoma. Eur J Surg Oncol 1999 0.76
137 Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma. J Surg Oncol 1998 0.76
138 No evidence for c-erbB-2 overexpression in gastric carcinogenesis. Histopathology 1998 0.75
139 Expression of somatostatin receptors in human pancreatic tumor. Pancreas 1998 0.75
140 Consequences of gastric surgery for benign conditions: an overview. Hepatogastroenterology 1988 0.75
141 [Cystadenomas with ovarian stroma in liver and pancreas: indications of embryonic migration of the gonadal epithelium]. Ned Tijdschr Geneeskd 2004 0.75
142 Partial gastrectomy: a risk factor for pancreatic cancer? J Natl Cancer Inst 1986 0.75
143 [Is the operated stomach a precancerous condition?]. ZFA (Stuttgart) 1983 0.75
144 [The importance of clinical characteristics in familial adenomatous polyposis]. Ned Tijdschr Geneeskd 1988 0.75
145 [Carcinoma with premalignant changes in stomach biopsies of patients having undergone a stomach operation more than 15 years ago]. Ned Tijdschr Geneeskd 1984 0.75
146 Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects. Gastrointest Endosc Clin N Am 1997 0.75
147 Pancreatic cancer--more familial than you thought. Anal Cell Pathol 1999 0.75
148 Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Ann Oncol 1999 0.75
149 [Carcinoma of the gastric stump]. Ned Tijdschr Geneeskd 1983 0.75
150 Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract. Hepatogastroenterology 1999 0.75
151 [Mortality from stomach carcinoma following stomach surgery for benign disorders; analysis of an Amsterdam cohort]. Ned Tijdschr Geneeskd 1988 0.75
152 Effect of partial gastrectomy on serum anti-Helicobacter pylori immunoglobulins in peptic ulcer patients. Dig Dis Sci 1991 0.75
153 No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol 1998 0.75
154 [Is the resected stomach a premalignant condition?]. Ned Tijdschr Geneeskd 1983 0.75
155 Barrett esophagus and cancer: pathogenesis, carcinogenesis, and diagnostic dilemmas. Histol Histopathol 1999 0.75
156 Dutch respelling rules for English and German medical word lists. Methods Inf Med 1987 0.75